Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Oxford BioMedica ( (GB:OXB) ) has provided an announcement.
Oxford BioMedica PLC has announced a change in its major holdings, as Briarwood Chase Management LLC, with its registered office in New York, USA, has acquired a 5.1219% voting rights stake in the company. This acquisition signifies a noteworthy shift in the ownership structure of Oxford BioMedica, potentially impacting its governance and strategic direction, while also reflecting broader investor interest in the biopharmaceutical sector.
More about Oxford BioMedica
Oxford BioMedica PLC is a UK-based company in the biopharmaceutical industry, specializing in the development and commercialization of gene and cell therapy products. The company focuses on providing innovative therapies for various medical conditions, leveraging cutting-edge biotechnological advancements.
YTD Price Performance: -6.25%
Average Trading Volume: 1,746
Technical Sentiment Consensus Rating: Hold
Current Market Cap: $507.9M
Learn more about OXB stock on TipRanks’ Stock Analysis page.
